-
Why Chinese CROs, low-key all the time, financed in a high-key manner in 2017?
Sinohealth
May 04, 2018
Contract research organization rose at the beginning of 1980s. The rise of the Chinese CRO industry was more than a decade later than the Europe and America
-
Top 50 Drugs by Global Sales in 2017: Humira Topped for 6 Times
Dopine
March 06, 2018
Humira continued to be strong, with sales of 2017 fiscal year growing by USD 2.69 billion to reach USD 18.427 billion in total, becoming a “6-time champion”.
-
9 Characteristics of China’s Pharmaceutical Foreign Trade in 2017
CCCMHPIE
March 05, 2018
9 Characteristics of China’s Pharmaceutical Foreign Trade seen from the data of CCCMHPI in 2017
-
CCCMHPIE: Data of China’s Pharmaceutical Foreign Trade in 2017
CCMHPIE
March 05, 2018
Data and trends seen from the Data of China’s Pharmaceutical Foreign Trade in 2017 by CCMHPI
-
Crushing Defeats—Top Ten R&D Pipelines that Failed in the Second Half of 2017
Blackaka
February 11, 2018
Although the Phase I through Phase III failure rate is 90-95%, the odds of success may still be improved in the next generation of drugs launched.
-
CDER’s Drug Therapy Approvals of 2017
FDA
February 09, 2018
Drugs designated First-in-Class and those approved to treat patients with rare diseases often have a strong positive impact on patient health.
-
Roche reports good results in 2017
worldpharmanews
February 06, 2018
In 2017, Roche Group sales rose 5% to CHF 53.3 billion.
-
Winter is Coming! —Events of the Chinese API Industry in 2017
Caicai
January 12, 2018
Winter is Coming! This line of the Game of Thrones well-known in the world may be used to best describe the current situation of the Chinese API industry.
-
Disappointing Pharmaceutical Enterprises and Products in 2017
Yaozh.com
January 11, 2018
Hope that those painful lessons can lead pharmaceutical enterprises towards a brighter future in 2018.
-
Summary of M&As in 2017
Dopine
January 08, 2018
2018 is here. I’d like to summarize characteristics of the M&As in the pharmaceutical field of 2017.